Doheny Eye Institute
Doheny Eye Institute
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Doheny Eye Institute? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
The Doheny Eye Institute was founded with authentic passion for finding cures to all disease that limits human sight. Mrs. Carrie Estelle Doheny, wife of the prominent Los Angeles oilman Edward L. Doheny, lost the sight in her left eye at the age of 69. Suddenly aware of the precious and delicate nature of the gift of sight, Mrs. Doheny created and funded the organization named for her in 1947. Doheny Eye Institute expects to serve thousands of patients in clinics around Los Angeles and Orange Counties. We have emerged as a world leader in basic and clinical vision research and advanced patient care. The Institute's innovative research programs continually result in new diagnostic and treatment procedures and are respected internationally for research of the highest caliber.
About
THE MISSION OF THE DOHENY EYE INSTITUTE (DEI), TO FURTHER THE CONSERVATION, IMPROVEMENT AND RESTORATION OF HUMAN EYESIGHT, IS GUIDED BY THE FOLLOWING OBJECTIVES: 1. TO INCREASE KNOWLEDGE OF THE HUMAN EYE, ITS CONDITIONS AND DISEASES, THROUGH RESEARCH; 2. TO TRANSMIT THIS KNOWLEDGE THROUGH EDUCATION, TRAINING, AND COMMUNITY SERVICE; AND 3. TO FACILITATE THE APPLICATION OF ITS RESEARCH TO IMPROVE PATIENT CARE AND FOSTER FURTHER RESEARCH. RESEARCH ACTIVITIES FOR THE PERIOD AND SELECTED FOR LONG-TERM FOCUS INCLUDE: RETINAL AND MACULAR DEGENERATION RESEARCH THROUGH THE STUDY OF RETINAL PIGMENT EPITHELIUM, RETINAL CELL TRANSPLANTATION, MOLECULAR GENETICS OF INHERITED DISEASES OF THE RETINA AND GENE THERAPY FOR RETINAL DISORDERS; MODIFICATION OF CORNEAL SHAPE AND MORPHOLOGY THROUGH CORNEAL RESEARCH AND REFRACTIVE SURGERY INNOVATIONS; AND REGENERATION OF DAMAGED OPTIC NERVE. On December 18, 2013, the Doheny Eye Institute executed an agreement with the University of California at Los Angeles (UCLA) for a 99 year affiliation. The purpose of this affiliation is to carry out the Institute's mission -- to further the conservation, improvement, and restoration of human eyesight -- through research, education, and clinical care (clinical care is provided directly by UCLA). Both the Institute and UCLA-Stein Eye Institute are dedicated to providing the public with the highest quality of ophthalmic care and the most innovative and strategic research for the improvement of human eyesight. New Areas of Research DEIs glaucoma clinician scientist has research projects that include the use of optical coherence tomography, and the angiographic visualization of aqueous humor outflow in the eye. NASA recently announced the selection of his study as part of their plan to support astronaut vision health for missions to the moon and Mars; DEI has proposed a novel countermeasure approach to prevent the development of optic disc edema, with part of the study to be conducted in a state of the art, ground-based, spaceflight analog facility in Cologne, Germany. DEI has developed a pioneering Adaptive Optics imaging instrument that integrates scanning laser ophthalmoscopy and optical coherence tomography (AO-SLO-OCT). This instrument can image the retina with a 3-D spatial resolution of 2.5 m x 2.5 m x 5 m, allowing for in-vivo ultrastructure assessment of reticular pseudodrusen and individual photoreceptors in both en face and cross-sectional planes. This Adaptive Optics imaging overcomes the limitations presented by optical defects in living eyes, allowing for high resolution images of the choriocapillaris in the study of various chorioretinal diseases, including Age-Related Macular Degeneration. DEI is using calcium imaging with confocal microscopy to characterize the effects of oxidative stress on the retinal ganglion cells to identify the early, emerging deficits in their electrophysiological function resulting from mitochondrial dysfunction. By carefully analyzing even the earliest signs of changes to photoreceptor response waveform and synaptic output to bipolar cells, their detection and interpretation could lead to diagnostic clues that warn of dysfunction and act to aid detection of persons at higher risk. DEI is researching the early stages of inflammation mediated degeneration of blood vessels, focusing on the atrophy of retinal vessels in Diabetic Retinopathy and the choriocapillaris/choroid in Age-Related Macular Degeneration. This integration of the principles of diabetes, retinal inflammation, vascular mechanobiology, and clinical trial treatment has led to a unique interdisciplinary approach that has the potential to identify other previously unrecognized mechanochemical mechanisms underlying DR pathogenesis.
Interesting data from their 2020 990 filing
The filing sets forth the mission of the non-profit as “To further the conservation, improvement and restoration of human eyesight" (mrs. doheny - 1947).”.
When detailing its responsibilities, they were listed as: “To further the conservation, improvement and restoration of human eyesight.”.
- The state in which the non-profit is legally permitted to operate is CA.
- The address of the non-profit for 2020 according to the filing is PO BOX 86228, LOS ANGELES, CA, 90086.
- The number of employees reported by the non-profit on their form as of 2020 is 185.
- Does not operate a hospital.
- Does not operate a school.
- Does not collect art.
- Does not provide credit counseling.
- Does not have foreign activities.
- Is not a donor-advised fund.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $2,830,419.
- The CEO compensation structure within the organization is based on a review and approval from a neutral party.
- The organization has a written policy that describes how long it will retain documents.
- The organization has 14 independent voting members.
- The organization has a professional fund raiser.
- The organization was formed in 1947.
- The organization has a written policy that addresses conflicts of interest.
- The organization is required to file Schedule B.
- The organization is required to file Schedule J.
- The organization is required to file Schedule O.
- The organization pays $13,329,897 in salary, compensation, and benefits to its employees.
- The organization pays $1,143,876 in fundraising expenses.
- The organization provides Form 990 to its governing body.
- The organization has minutes of its meetings.
- The organization has a written whistleblower policy.
- The organization's financial statements were reviewed by an accountant.